Capital Bank & Trust’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-119,922
| Closed | -$11.7M | – | 128 |
|
|
2021
Q2 | $11.7M | Sell |
119,922
-1,078
| -0.9% | -$105K | 0.14% | 124 |
|
|
2021
Q1 | $11.8M | Sell |
121,000
-108,880
| -47% | -$10.6M | 0.14% | 124 |
|
|
2020
Q4 | $22M | Sell |
229,880
-2,354
| -1% | -$226K | 0.27% | 93 |
|
|
2020
Q3 | $22.3M | Sell |
232,234
-46,128
| -17% | -$4.44M | 0.3% | 84 |
|
|
2020
Q2 | $34M | Buy |
278,362
+1,615
| +0.6% | +$197K | 0.5% | 59 |
|
|
2020
Q1 | $24M | Sell |
276,747
-12,418
| -4% | -$1.07M | 0.4% | 69 |
|
|
2019
Q4 | $31.1M | Sell |
289,165
-2,617
| -0.9% | -$281K | 0.4% | 72 |
|
|
2019
Q3 | $26.3M | Sell |
291,782
-31,032
| -10% | -$2.8M | 0.36% | 72 |
|
|
2019
Q2 | $27.2M | Buy |
322,814
+106,796
| +49% | +$9M | 0.34% | 80 |
|
|
2019
Q1 | $19M | Buy |
216,018
+168,394
| +354% | +$14.8M | 0.24% | 93 |
|
|
2018
Q4 | $3.4M | Buy |
47,624
+47,554
| +67,934% | +$3.4M | 0.05% | 150 |
|
|
2018
Q3 | $9K | Hold |
70
| – | – | ﹤0.01% | 672 |
|
|
2018
Q2 | $7K | Buy |
+70
| New | +$7K | ﹤0.01% | 564 |
|